Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Is there a rationale for switching from one anti-tumor necrosis factor agent to another?

× No keyword cloud information.

5 in total

1. Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis.

Authors: A Finckh; J F Simard; C Gabay; P-A Guerne
Journal: Ann Rheum Dis Date: 2005-12-08 Impact factor: 19.103

2. Efficacy and safety of switching from infliximab to adalimumab: a comparative controlled study.

Authors: S N Nikas; P V Voulgari; Y Alamanos; C G Papadopoulos; A I Venetsanopoulou; A N Georgiadis; A A Drosos
Journal: Ann Rheum Dis Date: 2005-06-23 Impact factor: 19.103

3. Is anti-TNF switching in refractory Still's disease safe and effective?

Authors: Nadia Emi Aikawa; Ana Cristina de Medeiros Ribeiro; Carla Gonçalves Schain Saad; Rosa Maria Rodrigues Pereira; Mauricio Levy; Clovis A Silva; Eloísa Bonfá; Jozélio Freire de Carvalho
Journal: Clin Rheumatol Date: 2011-04-05 Impact factor: 3.650

4. Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?

Authors: A Finckh; A Ciurea; L Brulhart; B Möller; U A Walker; D Courvoisier; D Kyburz; J Dudler; C Gabay
Journal: Ann Rheum Dis Date: 2009-05-04 Impact factor: 19.103

5. Effects of switching between anti-TNF therapies on HAQ response in patients who do not respond to their first anti-TNF drug.

Authors: K L Hyrich; M Lunt; W G Dixon; K D Watson; D P M Symmons
Journal: Rheumatology (Oxford) Date: 2008-04-17 Impact factor: 7.580

5 in total